Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1972 Aug;34(8):847–850. doi: 10.1136/hrt.34.8.847

Clinical evaluation of oxprenolol in angina pectoris.

G Sandler, A Pistevos
PMCID: PMC486991  PMID: 4560824

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELLET S., ELIAKIM M., DELIYIANNIS S., LAVAN D. Radioelectrocardiography during exercise in patients with angina pectoris. Comparison with the postexercise electrocardiogram. Circulation. 1962 Jan;25:5–14. doi: 10.1161/01.cir.25.1.5. [DOI] [PubMed] [Google Scholar]
  2. Birkett D. A., Chamberlain D. A. Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment. Br Med J. 1966 Aug 27;2(5512):500–502. doi: 10.1136/bmj.2.5512.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brunner H., Hedwall P. R., Meier M. Pharmakologische Untersuchungen mit 1-Isopropylamono-3-(o-allyloxyphenoxy)-2-propanol-hydrochlorid, einem adrenergischen beta-Receptorenblocker. Arzneimittelforschung. 1968 Feb;18(2):164–170. [PubMed] [Google Scholar]
  4. GILLAM P. M., PRICHARD B. N. USE OF PROPRANOLOL IN ANGINA PECTORIS. Br Med J. 1965 Aug 7;2(5457):337–339. doi: 10.1136/bmj.2.5457.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GREINER T., GOLD H., CATTELL M., TRAVELL J., BAKST H., RINZLER S. H., BENJAMIN Z. H., WARSHAW L. J., BOBB A. L., KWIT N. T. A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin). Am J Med. 1950 Aug;9(2):143–155. doi: 10.1016/0002-9343(50)90017-9. [DOI] [PubMed] [Google Scholar]
  6. Grandjean T., Rivier J. L. Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba. Br Heart J. 1968 Jan;30(1):50–59. doi: 10.1136/hrt.30.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grant R. H., Keelan P., Kernohan R. J., Leonard J. C., Nancekievill L., Sinclair K. Multicenter trial of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):361–365. doi: 10.1016/0002-9149(66)90054-3. [DOI] [PubMed] [Google Scholar]
  8. LEUALLEN E. C., FOWLER W. S. Maximal midexpiratory flow. Am Rev Tuberc. 1955 Dec;72(6):783–800. doi: 10.1164/artpd.1955.72.6.783. [DOI] [PubMed] [Google Scholar]
  9. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  10. Nayler W. G., Chipperfield D., Lowe T. E. The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle. Cardiovasc Res. 1969 Jan;3(1):30–36. doi: 10.1093/cvr/3.1.30. [DOI] [PubMed] [Google Scholar]
  11. Prichard B. N., Gillam P. M. Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise. Br Heart J. 1971 Jul;33(4):473–480. doi: 10.1136/hrt.33.4.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. RISEMAN J. E., ALTMAN G. E., KORETSKY S. Nitroglycerin and other nitrites in the treatment of angina pectoris; comparison of six preparations and four routes of administration. Circulation. 1958 Jan;17(1):22–39. doi: 10.1161/01.cir.17.1.22. [DOI] [PubMed] [Google Scholar]
  13. Sandler G., Clayton G. A. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris. Br Med J. 1970 May 16;2(5706):399–402. doi: 10.1136/bmj.2.5706.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sandler G., Clayton G. A., Thornicroft S. G. Clinical evaluation of verapamil in angina pectoris. Br Med J. 1968 Jul 27;3(5612):224–227. doi: 10.1136/bmj.3.5612.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sharma B., Meeran M. K., Galvin M. C., Tulpule A. T., Whitaker W., Taylor S. H. Comparison of adrenergic beta-blocking drugs in angina pectoris. Br Med J. 1971 Jul 17;3(5767):152–155. doi: 10.1136/bmj.3.5767.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
  17. Waal H. J. Hypotensive, antiarrhythmic and chronotropic action of Trasicor (Ciba 39089--Ba). N Z Med J. 1968 Mar;67(429):291–295. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES